Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-Cycloserine for Serine Palmitoyltransferase Inhibition: Treatment of a Single Patient With a Complex Hereditary Spastic Paraplegia Due to a De Novo Variant in the SPTSSA Gene

NCT07542548 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07542548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-Cycloserine for Serine Palmitoyltransferase Inhibition: Treatment of a Single Patient With a Complex Hereditary Spastic Paraplegia Due to a De Novo Variant in the SPTSSA Gene
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 10, 2024
Completion date
March 17, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary spastic paraplegia